Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy
- PMID: 24931665
- DOI: 10.1586/14737175.2014.928203
Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy
Abstract
Juvenile myoclonic epilepsy (JME) is a clinically and genetically heterogenous, generalized epilepsy syndrome usually starting in adolescence. An age-related, predominantly frontocortical-subcortical network dysfunction is likely to be the substrate of bilateral myoclonic seizures occurring at full consciousness within hours after awakening, which are the clinical hallmark of JME. Although essential features of JME were recognized by Herpin more than 140 years ago, it is still an enigmatic epilepsy syndrome in many ways; advanced imaging techniques reveal multi-focal abnormalities in this paradigmatic generalized epilepsy syndrome; clinical studies reveal a major role of genetics in etiology, but the underlying molecular changes are likely to be highly heterogeneous; many JME patients have psycho-social issues, even though their intelligence is normal; antiepileptic drugs (AEDs), notably valproic acid, achieve seizure remission in two thirds of patients, but more patients seem to relapse after stopping AEDs than in any other epilepsy syndrome. This pessimistic outlook has been challenged in recent population-based studies and needs to be assessed in randomized AED withdrawal trials. This review summarizes recent focus neuroimaging, genetic, and behavioral aspects of JME and re-appraises the entrenched view that remission off AEDs is exceptionally rare in JME.
Keywords: behavioral problem; drug treatment; epileptogenesis; genetics; juvenile myoclonic epilepsy; neuroimaging; remission; valproic acid.
Similar articles
-
[Juvenile myoclonic epilepsy].Rev Neurol. 2001 May 16-31;32(10):957-61. Rev Neurol. 2001. PMID: 11424054 Spanish.
-
Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.Arch Neurol. 2003 Aug;60(8):1100-5. doi: 10.1001/archneur.60.8.1100. Arch Neurol. 2003. PMID: 12925366
-
Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy.Seizure. 2018 Jul;59:116-122. doi: 10.1016/j.seizure.2018.05.015. Epub 2018 May 20. Seizure. 2018. PMID: 29807291
-
Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.Paediatr Drugs. 2006;8(5):303-10. doi: 10.2165/00148581-200608050-00003. Paediatr Drugs. 2006. PMID: 17037947 Review.
-
Juvenile myoclonic epilepsy--neuroimaging findings.Epilepsy Behav. 2013 Jul;28 Suppl 1:S40-4. doi: 10.1016/j.yebeh.2012.06.035. Epilepsy Behav. 2013. PMID: 23756478 Review.
Cited by
-
Hyperconnectivity in juvenile myoclonic epilepsy: a network analysis.Neuroimage Clin. 2014 Nov 27;7:98-104. doi: 10.1016/j.nicl.2014.11.018. eCollection 2015. Neuroimage Clin. 2014. PMID: 25610771 Free PMC article.
-
Altered dynamic effective connectivity of the default mode network in newly diagnosed drug-naïve juvenile myoclonic epilepsy.Neuroimage Clin. 2020;28:102431. doi: 10.1016/j.nicl.2020.102431. Epub 2020 Sep 11. Neuroimage Clin. 2020. PMID: 32950903 Free PMC article.
-
Myoclonic Disorders.Brain Sci. 2017 Aug 14;7(8):103. doi: 10.3390/brainsci7080103. Brain Sci. 2017. PMID: 28805718 Free PMC article. Review.
-
Progressive dissociation of cortical and subcortical network development in children with new-onset juvenile myoclonic epilepsy.Epilepsia. 2018 Nov;59(11):2086-2095. doi: 10.1111/epi.14560. Epub 2018 Oct 3. Epilepsia. 2018. PMID: 30281148 Free PMC article.
-
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies.Nat Commun. 2018 Dec 10;9(1):5269. doi: 10.1038/s41467-018-07524-z. Nat Commun. 2018. PMID: 30531953 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical